EX-32.1
Published on November 23, 2009
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of NeoGenomics, Inc. (the Company) on Form 10-Q for
the three months ended September 30, 2009 as filed with the Securities and Exchange Commission on
the date hereof (the Report), each of the undersigned, in the capacities and on the dates
indicated below, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
Date: November 23, 2009 | /s/ Douglas M. VanOort | |||
Douglas M. VanOort | ||||
Executive Chairman and Chief Executive Officer | ||||
Date: November 23, 2009 | /s/ Steven C. Jones | |||
Steven C. Jones | ||||
Acting Principal Financial Officer | ||||
Date: November 23, 2009 | /s/ Jerome J. Dvonch | |||
Jerome J. Dvonch | ||||
Director of Finance and Principal Accounting Officer | ||||
The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C.
§ 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934,
as amended, and is not to be incorporated by reference into any filing of the Company, whether made
before or after the date hereof, regardless of any general incorporation language in such filing.
A signed original of this written statement required by Section 906, or other document
authenticating, acknowledging, or otherwise adopting the signature that appears in typed form
within the electronic version of this written statement required by Section 906, has been provided
to the Company and will be retained by the Company and furnished to the Securities and Exchange
Commission or its staff upon request.